PURPOSE There is increasing interest in implementing digital systems for remote
monitoring of patients' symptoms during routine oncology practice. Information is limited …

Abstract Purpose Symptomatic adverse events (AEs) are monitored by clinicians as part of
all US-based clinical trials in cancer via the US National Cancer Institute's Common …

Importance To integrate the patient perspective into adverse event reporting, the National
Cancer Institute developed a patient-reported outcomes version of the Common …

The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …

Summary Background The standardized Clavien-Dindo classification of surgical
complications is applied as a simple and widely used tool to assess and report …

Systematic capture of the patient perspective can inform the development of new cancer
therapies. Patient-reported outcomes (PROs) are commonly included in cancer clinical trials; …

Background: The Patient-Reported Outcomes version of the Common Terminology Criteria
for Adverse Events is an item library designed for eliciting patient-reported adverse events in …

Symptomatic toxicities associated with anticancer treatments, such as nausea and vomiting,
are frequently underreported by clinicians, even when data are prospectively collected …

CANCER IS A TERM USED TO describe a group of more than 100 multifactorial diseases in
which abnormal cells reproduce in an uncontrolled manner and are able to spread to other …

We characterized the landscape and drug sensitivity of ERBB2 (HER2) mutations in
cancers. In 11 datasets (n= 211,726), ERBB2 mutational hotspots varied across 25 tumor …